First Eagle Investment Management’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,462,983
Closed -$3.58M 452
2025
Q4
$3.58M Buy
1,462,983
+224,088
+18% +$973K 0.01% 282
2025
Q3
$8.31M Buy
1,238,895
+330,866
+36% +$2.16M 0.02% 192
2025
Q2
$5.34M Buy
908,029
+409,105
+82% +$2.67M 0.01% 247
2025
Q1
$4.19M Buy
+498,924
New +$4.48M 0.01% 273

Other funds holding TMCI

First Eagle Investment Management's TMCI Position: Q1 2026 in Review

First Eagle Investment Management sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 1,462,983 shares — an estimated $3.58M sold.

First Eagle Investment Management first reported a position in TMCI in Q1 2025 and held it in 4 quarters. The position peaked at $8.31M in Q3 2025. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • First Eagle Investment Management reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • First Eagle Investment Management sold 1,462,983 Treace Medical Concepts shares in Q1 2026, an estimated $3.58M.
  • First Eagle Investment Management first reported a position in Treace Medical Concepts in Q1 2025 and held it in 4 quarters.
  • First Eagle Investment Management's Treace Medical Concepts position peaked at $8.31M in Q3 2025.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on First Eagle Investment Management's 13F filing for Q1 2026, filed 12 May 2026.